Rolling Out6d
Crohn’s disease and the symptoms no one talks about
Crohn’s disease isn’t just about digestion. From joint pain to vision issues, its hidden symptoms affect the body in unexpected ways.
Science Daily2d
Crohn's Disease News
Treating Newly-Diagnosed Crohn's Patients With Advanced Therapy Leads to Dramatic Improvements in Outcomes Feb. 22, 2024 — A large-scale clinical ... may reduce disease symptoms and improve ...
TAU makes breakthrough in drug delivery to treat inflammatory bowel disease
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
BlackDoctor.org3d
Crohn’s Disease, Black People, and the Barriers we Face
Let's dive deep into a topic that isn’t getting enough shine – Crohn's disease and how it's hitting the Black community.
PharmExec12d
Treating Disruptive Symptom’s in Crohn’s Patients: Q&A with Mark Genovese, MD
Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
MedPage Today3d
Exclusion Diet in Pediatric Crohn's Tied to Clinical Remission in Small Study
SAN FRANCISCO -- The pediatric Crohn's disease exclusion diet was associated with clinical remission for children with good ...
MedPage Today2d
Risankizumab Tops Competitor for Clinical Remission in Moderate-to-Severe CD
SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
EurekAlert!4d
Crohn's & Colitis Congress® spotlights key IBD research findings
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...
Medindia3d
Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two years
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Omvoh works to reduce inflammation within the gastrointestinal ...